Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

270
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
270
Respiration and Gaseous Exchange01:20

Respiration and Gaseous Exchange

1.6K
The intricate interplay between the cardiovascular and respiratory systems is crucial for efficiently transporting respiratory gases throughout the body. Let us explore the cardiovascular system's multifaceted functions, emphasizing its pivotal role in gas exchange.
Respiration involves the exchange of gases, especially oxygen (O2) and carbon dioxide (CO2), between the alveoli and body cells, a process facilitated by blood circulation. As a result, the cardiovascular system, which involves...
1.6K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

285
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
285
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

2.9K
Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
2.9K
Physiological Control of Respiration01:23

Physiological Control of Respiration

2.2K
Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
2.2K
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen01:16

Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen

726
Oxygen therapy is a pivotal aspect of medical care, particularly for patients with respiratory ailments. Two prominent oxygen-delivering systems include the Venturi mask and the transtracheal oxygen catheter.
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...
726

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eradication of Pseudomonas aeruginosa in Non-Cystic Fibrosis Bronchiectasis: A Multicentre Real-World Analysis.

Archivos de bronconeumologia·2026
Same author

Response.

Chest·2026
Same author

Progression of interstitial lung abnormalities and its impact on mortality in patients with lung cancer resection.

Chinese medical journal pulmonary and critical care medicine·2026
Same author

Association of bronchoalveolar lavage cellular analysis and radiological findings in fibrotic interstitial lung diseases.

BMJ open respiratory research·2026
Same author

Nintedanib in systemic sclerosis-associated interstitial lung disease: real-world cohort study on tolerability and discontinuation.

Clinical and experimental rheumatology·2026
Same author

Autonomic control as a mechanism of prolonged hypotension after acute aerobic exercise in individuals with normal and elevated blood pressure: a systematic review and meta-analysis.

Journal of hypertension·2026
Same journal

A hypermetabolic pulmonary lesion in a patient with breast cancer.

Breathe (Sheffield, England)·2026
Same journal

Rigid bronchoscopy is the gold standard management of inhaled foreign bodies in children: myth or maxim?

Breathe (Sheffield, England)·2026
Same journal

The price of immune awakening: bridging knowledge gaps in checkpoint inhibitor-related pneumonitis in lung cancer.

Breathe (Sheffield, England)·2026
Same journal

Where are we with biomarkers in paediatric asthma in 2026?

Breathe (Sheffield, England)·2026
Same journal

Recurrent invasive fungal infection with locally advanced thymoma: diagnostic challenges in complex mediastinal disease.

Breathe (Sheffield, England)·2026
Same journal

Elevated <i>D</i> <sub>LCO</sub> and pulmonary function evolution during treatment in a patient with hyperleukocytosis and leukostasis.

Breathe (Sheffield, England)·2026
See all related articles

Related Experiment Video

Updated: Jul 25, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.2K

Oxygen in interstitial lung diseases.

Ricardo Cordeiro1, André Nunes1, Oliver Smith2

  • 1Centro de Responsabilidade Integrada de Pneumologia, Hospital de Torres Vedras, Centro Hospitalar do Oeste, Torres Vedras, Portugal.

Breathe (Sheffield, England)
|June 28, 2023
PubMed
Summary
This summary is machine-generated.

Long-term oxygen therapy (LTOT) helps hypoxemic interstitial lung disease (ILD) patients with breathlessness and may improve survival. More research is needed on nocturnal oxygen and better delivery systems for ambulatory oxygen therapy (AOT).

More Related Videos

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.6K
Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on: August 3, 2021

2.4K

Related Experiment Videos

Last Updated: Jul 25, 2025

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury
14:48

Visualizing Lung Cellular Adaptations during Combined Ozone and LPS Induced Murine Acute Lung Injury

Published on: March 21, 2021

5.2K
Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents
09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

8.6K
Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
07:38

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome

Published on: August 3, 2021

2.4K

Area of Science:

  • Pulmonary Medicine
  • Respiratory Care

Background:

  • Domiciliary oxygen is crucial for hypoxemic interstitial lung disease (ILD) patients.
  • Current guidelines recommend long-term oxygen therapy (LTOT) for severe resting hypoxemia in ILD, with potential survival benefits extrapolated from COPD.
  • Pulmonary hypertension (PH) and right heart failure necessitate a lower hypoxemia threshold for LTOT initiation.

Purpose of the Study:

  • To review the current evidence and guidelines for domiciliary oxygen therapy in ILD.
  • To highlight the need for further research into nocturnal oxygen and ambulatory oxygen therapy (AOT).
  • To identify challenges and unmet needs in oxygen delivery systems for ILD patients.

Main Methods:

  • Literature review of existing guidelines and studies on oxygen therapy in ILD.
  • Analysis of evidence regarding resting, nocturnal, and exertional hypoxemia.
  • Discussion of the impact of oxygen therapy on quality of life, exercise tolerance, and survival.

Main Results:

  • LTOT is recommended for severe resting hypoxemia in ILD, with potential benefits for breathlessness, disability, and survival.
  • Nocturnal hypoxemia's link to PH and poor survival warrants urgent investigation.
  • AOT shows promise for exertional hypoxemia, improving quality of life, though evidence is limited and guidelines vary.

Conclusions:

  • Domiciliary oxygen therapy, including LTOT and AOT, plays a vital role in managing hypoxemic ILD.
  • Further research is essential to optimize oxygen use, particularly for nocturnal and exertional hypoxemia.
  • Development of improved oxygen delivery systems is needed to mitigate patient burden and enhance AOT effectiveness.